Clinical Trials Directory

Trials / Unknown

UnknownNCT00674960

Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease)

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
GAAD Medical Research Institute Inc. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Pick's disease, also known as Pick disease,or FTD is a rare fronto-temporal neurodegenerative disease. This study will investigate the use of far infrared radiation for the control, management and treatment of Pick's disease.

Detailed description

This disorder causes progressive destruction of nerve cells in the brain and causes tau proteins to accumulate into the "Pick bodies" that are a defining characteristic of the disease. Tau proteins are microtubule-associated proteins that are abundant in neurons in the central nervous system and are less common elsewhere. Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells. It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have FTD.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiation: Far Infrared Radiation (5μm to 20μm wavelength)Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.

Timeline

Start date
2008-05-01
Primary completion
2009-05-01
Completion
2009-10-01
First posted
2008-05-08
Last updated
2009-08-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00674960. Inclusion in this directory is not an endorsement.